Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0Z7DA
|
|||
Drug Name |
PMID25656651-Compound-18
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
IRM LLC HUANG, Shenlin LIU, Zuosheng ALBAUGH, Pamela, A. WANG, Xing PAN, Shifeng XIE, Yongping ZHANG, Guobao
|
|||
Structure |
Download2D MOL |
|||
Formula |
C22H19F3N8O
|
|||
Canonical SMILES |
CC1=C(C=C(C=C1)NC(=O)C2=CC(=CC=C2)C(F)(F)F)NC3=NC=NN3C4=NC=NC(=C4)NC
|
|||
InChI |
1S/C22H19F3N8O/c1-13-6-7-16(31-20(34)14-4-3-5-15(8-14)22(23,24)25)9-17(13)32-21-29-12-30-33(21)19-10-18(26-2)27-11-28-19/h3-12H,1-2H3,(H,31,34)(H,26,27,28)(H,29,30,32)
|
|||
InChIKey |
ZHABTPLXVWUNPN-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Fusion protein Bcr-Abl (Bcr-Abl) | Target Info | Inhibitor | [1] |
Target's Patent Info | Fusion protein Bcr-Abl (Bcr-Abl) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Bcr-Abl tyrosine kinase inhibitors: a patent review.Expert Opin Ther Pat. 2015 Apr;25(4):397-412. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.